| Literature DB >> 36211506 |
Zhexin Ren1, Fei Yang2, Sijia Yao1, Lijun Bi3, Guanqin Jiang1, Ju Huang1,4, Yunping Tang1.
Abstract
This study aimed to investigate the immunomodulatory activation of low-molecular-weight peptides from monkfish (Lophius litulon) roe (named MRP) on cyclophosphamide (CTX)-induced immunosuppressed mice. Our results indicated that MRP (100 mg/kg/d BW) could significantly increase the body weight and immune organ index, and improve the morphological changes in the spleen and thymus of mice. These effects subsequently enhance the serum levels of interleukin (IL)-6, IL-1β, tumor necrosis factor (TNF)-α, and immunoglobulin (Ig) A, IgM, and IgG. Furthermore, MRP could also improve CTX-induced oxidative stress, and activate the NF-κB and MAPK pathways in the spleen tissues. The findings reported herein indicate that MRP has a good immunomodulatory activation toward immunosuppressed mice, hence can potentially be developed as an immune adjuvant or functional food.Entities:
Keywords: (Lophius litulon) roe; NF-κB and MAPK pathways; immunomodulatory; immunosuppression; low molecular weight peptides
Year: 2022 PMID: 36211506 PMCID: PMC9532971 DOI: 10.3389/fnut.2022.929105
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1The experimental protocol was performed in the present study.
Figure 2Molecular weight (MW) distribution of MRP.
Figure 3Amino acid composition of MRP.
Figure 4Effect of MRP on body weight (A) and immune organ index (B) in CTX-treated mice (n = 10). ##P < 0.01 vs. Control; **P < 0.01 vs. Model.
Figure 5Histomorphology of the spleen (A) and thymus (B) in mice (×100).
Figure 6Effect of MRP on serum levels of IL-6 (A), IL-1β (B), TNF-α (C), IgA (D), IgM (E), and IgG (F) (n = 10). #P < 0.05 and ##P < 0.01 vs. Control; *P < 0.05 and **P < 0.01 vs. Model.
Effect of MRP on the oxidative stress indices of the spleen.
|
|
|
|
|
|---|---|---|---|
| MDA (nmol/mg prot) | 2.56 ± 0.22 | 4.59 ± 0.09 | 3.17 ± 0.15 |
| T-AOC (μmol/mg prot) | 14.60 ± 1.75 | 2.40 ± 0.38 | 6.55 ± 0.54 |
| CAT (U/mg prot) | 22.15 ± 1.74 | 7.93 ± 0.60 | 20.24 ± 1.35 |
| SOD (U/mg prot) | 13.78 ± 0.42 | 8.21 ± 0.83 | 11.25 ± 1.21 |
| GSH-Px (U/mg prot) | 20.40 ± 0.55 | 15.09 ± 1.29 | 18.20 ± 0.51 |
P < 0.05 and
P < 0.01 vs. Control;
P < 0.05 and
P < 0.01 vs. Model.
Figure 7Effect of MRP on the protein levels in the NF-κB and MAPK pathways (n = 3). (A) Western blot of NF-κB pathway. (B) The protein levels of related proteins in the NF-κB pathway. (C) Western blot of MAPK pathway. (D) Protein levels of related proteins in the MAPK pathway. ##P < 0.01 vs. Control; *P < 0.05 and **P < 0.01 vs. Model.
Figure 8A potential signaling pathway involved in the immune-enhancement of CTX-induced immunosuppressed mice.